Literature DB >> 33862068

Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.

Andreas Willerslev-Olsen1, Lise Mette Rahbek Gjerdrum2, Lise M Lindahl3, Terkild B Buus1, Emil M H Pallesen1, Maria Gluud1, Michael Bzorek4, Boye S Nielsen5, Maria R Kamstrup6, Anne Hald Rittig3, Charlotte M Bonefeld1, Thorbjørn Krejsgaard1, Carsten Geisler1, Sergei B Koralov7, Thomas Litman1, Jurgen C Becker8, Anders Woetmann1, Lars Iversen3, Niels Odum9.   

Abstract

Staphylococcal enterotoxins are believed to fuel disease activity in cutaneous T-cell lymphoma. Recent data support this by showing that antibiotics inhibit malignant T cells in skin lesions in mycosis fungoides and Sézary syndrome, the most common forms of cutaneous T-cell lymphoma. Yet, it remains incompletely characterized how staphylococcal enterotoxins fuel disease activity. In this study, we show that staphylococcal enterotoxins induce the expression of the oncogenic microRNA miR-155 in primary malignant T cells. Thus, staphylococcal enterotoxins and Staphyloccocus aureus isolates from lesional skin of patients induce miR-155 expression at least partly through the IL-2Rg‒Jak‒signal transducer and activator of transcription 5 pathway, and the effect is augmented by the presence of nonmalignant T cells. Importantly, mycosis fungoides lesions harbor S. aureus, express Y-phosphorylated signal transducer and activator of transcription 5, and display enhanced miR-155 expression, when compared with nonlesional and healthy skin. Preliminary data show that aggressive antibiotic therapy is associated with decreased Y-phosphorylated signal transducer and activator of transcription 5 and miR-155 expression in lesional skin in two patients with Sézary syndrome. In conclusion, we show that S. aureus and its enterotoxins induce enhanced expression of oncogenic miR-155, providing mechanistic insight into the role of S. aureus in cutaneous T-cell lymphoma. Our findings support that environmental stimuli such as bacteria can fuel disease progression in cutaneous T-cell lymphoma.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33862068     DOI: 10.1016/j.jid.2021.01.038

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ.

Authors:  Ying Liu; Meng Wang; Ting Deng; Rui Liu; Tao Ning; Ming Bai; Guoguang Ying; Haiyang Zhang; Yi Ba
Journal:  Cancer Biol Med       Date:  2022-02-19       Impact factor: 5.347

Review 2.  The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides.

Authors:  Pengfei Wen; Yao Xie; Lin Wang
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

3.  Recurrent Bacterial Infections in Cutaneous T-cell Lymphoma.

Authors:  Bharadwaj Adithya Sateesh; Yash V Bhagat; Sneha E Thomas; Aseem Sood; Miriam B Michael
Journal:  Cureus       Date:  2022-01-03

Review 4.  The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas.

Authors:  Marion Jost; Ulrike Wehkamp
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

5.  MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis.

Authors:  Xi Zhang; Jingjing Chen; Huimin Cheng; Jinying Zhu; Qiao Dong; Huan Zhang; Zeliang Chen
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

Review 6.  Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.

Authors:  Philipp Licht; Volker Mailänder
Journal:  Cells       Date:  2022-01-19       Impact factor: 6.600

Review 7.  The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review.

Authors:  Magdalena Łyko; Alina Jankowska-Konsur
Journal:  Pathogens       Date:  2022-08-18

Review 8.  Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Authors:  Karol Kołkowski; Magdalena Trzeciak; Małgorzata Sokołowska-Wojdyło
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.